PATH is trading at $16.40 (+3.3%) as the stock participates in today's strong broader market advance.

  • Q3 revenue exceeded expectations, reporting $411M against a $392M estimate.
  • Multiple analyst upgrades followed the earnings report, including RBC Capital raising its target to $19 and Truist Securities to $17.
  • The company recently secured inclusion in the S&P MidCap 400 index, potentially adding institutional demand.